Hematologic Malignancy clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
CB-Long-Term Safety Study (CB-LTSS)
Sorry, accepting new patients by invitation only
This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. Its purpose of is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies.
Irvine, California and other locations
Last updated: